Not Searching, But Reading: Russian AI Reshapes Medical Records
Irkutsk-based startup Accent has developed iambulant, an AI platform that automatically structures medical records. The company secured 15 million rubles (about $175,000) from an angel investor, showing how Russian innovation is reshaping healthcare data management.
Time for Physicians
Artificial intelligence may already be painting pictures and composing symphonies, but its most important work happens quietly—where human lives are at stake. A doctor, immersed in a thick medical chart, searches for the key to a diagnosis. Hours of meticulous review, the risk of missing a crucial detail in a sea of routine notes—this is the daily reality of healthcare worldwide. In Irkutsk, Russia, developers found a way to give physicians the most valuable resource: time.
Accent, a Skolkovo resident, developed the iambulant platform, which does more than assist: it revolutionizes workflows. The platform fully 'reads' and transforms unstructured medical notes into precise, structured digital copies. This is not just another keyword search algorithm, but a fundamentally new approach that lays the foundation for data-driven medicine.
The global market responded quickly. Within months of its launch, the startup attracted 15 million rubles (about $175,000) from a private angel investor. That investment is more than capital—it is a vote of confidence in Russia’s technological future.
From Siberian Idea to Skolkovo Investment
Accent’s path is a textbook success story of modern Russian IT. After becoming a Skolkovo resident in December 2024, the company impressed at Startup Village in May 2025, where it secured not only funding but also strategic partnerships. Investor Maria Ahulkova acquired a 7.5% stake in the company, recognizing the value of both its technology and its team.
“The iambulant platform has exceptionally high market potential,” Ahulkova emphasized. “This solution does more than address a specific task of improving healthcare staff efficiency. It creates a new standard for working with medical data, making it highly competitive in the rapidly expanding digital health market.”
At Skolkovo, the success is seen as natural. “A capable team can attract significant investment even at early stages. Such stories inspire other projects and confirm that Skolkovo’s ecosystem creates conditions for technology and business growth,” noted Alexey Pleskov, Director of Skolkovo’s Center for Technology Development in Biology, Medicine, and Agriculture.
Why iambulant Has No Analogs
Solutions for managing medical data exist both in Russia and globally. However, most work only with formalized information, locking physicians into rigid templates. Other startups, such as Diagnostic or DocAI, automate only narrow processes. iambulant’s key distinction lies in its ability to process free-form natural language in medical notes.
The platform employs advanced NLP (Natural Language Processing) algorithms not just to extract data but to interpret context, relationships, and meaning. It transforms messy notes into clear, machine-readable structures: diagnoses, prescriptions, test results, medical history—all instantly available for analysis.
From Doctor to Healthcare System
The impact of this technology is systemic. For physicians, it frees up hours of routine work. Instead of combing through piles of paper or PDFs, doctors receive structured summaries that enable immediate decision-making. This reduces burnout and improves diagnostic accuracy, making doctors’ work significantly more efficient.
For patients, the benefit is clear: more physician time is dedicated to them, not paperwork. Access to care improves, and treatment becomes more personalized.
For clinics and the broader healthcare system, the payoff is immense. Clean, structured data across all patients becomes a valuable asset. It allows for deeper analytics, identification of epidemiological trends, resource optimization, and a foundation for predictive analytics.
Looking Ahead
The company’s development roadmap is ambitious. Registration of the software as a medical device with Roszdravnadzor will open doors to hospitals nationwide. By 2025, pilot projects are expected to evolve into full commercial contracts.
This regulatory milestone will expand iambulant’s official market reach. With interest rates expected to fall, high-tech growth companies like Accent could become more attractive to investors, potentially paving the way to IPO opportunities.
The ambitions also extend beyond Russia. The platform’s ability to 'read' free-form medical text has global appeal for healthcare systems seeking data-driven strategies.
A Russian Tech Giant in the Making
Accent’s story is not an isolated success but a sign of the maturity of Russia’s IT ecosystem. It demonstrates that the country has it all: brilliant ideas born in Irkutsk, expertise to realize them, infrastructure through Skolkovo and VEB.RF, and private capital willing to take early risks.
iambulant is more than a startup. It is a verb—a sign that a technologically sovereign Russia is not chasing the future but shaping it. And in this future, Russian healthcare, powered by homegrown innovation, will be more efficient, accurate, and human-centered.
